Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Atopic dermatitis Age: Adult |
Dose: Cream – 1% Frequency: twice daily Note: Apply a thin layer onto the affected areas. Stop treatment if there is no improvement after 6 weeks or if there is worsening of eczema. |
|
Condition: Hepatic impairment |
Dose: Cream – 1% Note: Dosage reduction is necessary. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Atopic dermatitis Age: greater than 2 yr Condition: Topical/Cutaneous |
Dose: Cream – thin layer of 1% Frequency: twice daily Note: Stop treatment if there is no improvement after 6 wk or if there is worsening of eczema. |
|
Indication: Atopic dermatitis Age: greater than 2 yr Condition: Hepatic impairment |
Dose: Cream – thin layer of 1% Note: Dosage reduction is necessary. |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: Dosage reduction is necessary. Note: Renal impairment: Dosage reduction is necessary. |
Administration
- Apply thin layer to affected areas
- Use twice daily
Side Effect
- Burning sensation (2-26%)
- Headache (7-25%)
- Fever (1-13%)
- Nasopharyngitis (8-27%)
- Cough (2-16%)
- Bronchitis (Less than 11%)
- Upper respiratory tract infection (URTI) (4-19%)
- Basal cell carcinoma of skin
- Malignant melanoma
- Squamous cell carcinoma
- Malignant lymphoma
- Septic arthritis
- Skin discoloration
- Eczema
- Flushing
- Ocular irritation
- Skin infection
- Rash
- Application site pain
- Paraesthesia
- Desquamation
- Dryness
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Cytochrome P450 3A4 isoenzyme inhibitors
|
In patients with widespread and/or erythrodermic disease
|
|
Live vaccines
|
Potentially Fatal: Increased risk of infections
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Immunocompromised patients
|
Increased infection risk
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.